Laporan arus kas Viking Therapeutics, Inc. (VKTX)
NASDAQ · Healthcare · Biotechnology · Karyawan: 53 · CEO: Brian Lian
- Harga
- $27,28 +1,56%
- Kapitalisasi pasar
- $3,48 M
- Nilai perusahaan
- $3,06 M
- Laporan terakhir
- Q3 '26 diajukan 2026-10-29
- Laporan berikutnya
- 2027-02-10 Estimasi EPS: -$1,38
Pada Q3 '26, Viking Therapeutics, Inc. (VKTX): arus kas operasional -$138 jt, belanja modal –, arus kas bebas -$138 jt. Dalam empat kuartal terakhir arus kas bebas mencapai -$463 jt.
Arus kas
| Arus kas | Tren | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operasional | |||||||||||||
| Laba bersih | -$24,6 jt | -$27,4 jt | -$22,3 jt | -$24,9 jt | -$35,4 jt | -$45,6 jt | -$65,6 jt | -$90,8 jt | -$158 jt | -$158 jt | -$128 jt | -$183 jt | |
| Depresiasi & amortisasi | $74 rb | $74 rb | $75 rb | $87 rb | $110 rb | $111 rb | $112 rb | $114 rb | $94 rb | $85 rb | $157 rb | $0 | |
| Kompensasi berbasis saham | $4,08 jt | $7,98 jt | $7,08 jt | $8,98 jt | $5,67 jt | $11,3 jt | $13,5 jt | $7,34 jt | $8,59 jt | $10,3 jt | $11,1 jt | $17,9 jt | |
| Perubahan modal kerja | $5,48 jt | $16 jt | -$8,01 jt | -$1,03 jt | $2,46 jt | -$15,1 jt | $7,2 jt | -$8,64 jt | $65,5 jt | $35,2 jt | -$7,64 jt | $27,6 jt | |
| Pos non-kas lainnya | -$2,67 jt | -$2,78 jt | -$5,41 jt | -$5,06 jt | -$4 jt | -$3,1 jt | -$2,36 jt | -$2,02 jt | -$1,79 jt | -$1,29 jt | -$804 rb | -$547 rb | |
| Arus kas operasional | -$17,6 jt | -$6,13 jt | -$28,5 jt | -$22 jt | -$31,2 jt | -$52,3 jt | -$47,1 jt | -$94 jt | -$85,3 jt | -$114 jt | -$125 jt | -$138 jt | |
| Investasi | |||||||||||||
| Pembelian investasi | -$97,5 jt | -$597 jt | -$230 jt | -$150 jt | -$137 jt | -$233 jt | -$123 jt | -$21,5 jt | -$40,5 jt | -$72,4 jt | -$70,1 jt | -$12,3 jt | |
| Penjualan / jatuh tempo investasi | $133 jt | $137 jt | $104 jt | $176 jt | $144 jt | $296 jt | -$11 rb | $181 jt | $116 jt | $936 rb | $179 jt | $105 jt | |
| Aktivitas investasi lainnya | $0 | $0 | $0 | $0 | $0 | $0 | $166 jt | $0 | $0 | $126 jt | $0 | $0 | |
| Arus kas investasi | $35,7 jt | -$460 jt | -$126 jt | $25,9 jt | $6,58 jt | $63,2 jt | $42,5 jt | $160 jt | $75,6 jt | $54,2 jt | $109 jt | $92,5 jt | |
| Pendanaan | |||||||||||||
| Utang neto diterbitkan / dilunasi | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $251 jt | |
| Pendanaan lainnya (termasuk pajak atas saham yang vested) | -$270 jt | $8,92 jt | $2,93 jt | -$44,1 jt | $47,7 jt | $0 | $0 | $0 | $73,9 jt | $11,6 jt | $22,6 jt | $0 | |
| Arus kas pendanaan | $188 rb | $606 jt | $2,91 jt | $2,52 jt | $1 jt | $349 rb | $507 rb | $480 rb | $75,1 jt | $12,1 jt | $23,6 jt | $598 jt | |
| Ringkasan | |||||||||||||
| Efek kurs terhadap kas | $50 rb | -$48 rb | $3 rb | -$29 rb | -$74 rb | $1 rb | -$12 rb | -$6 rb | $9 rb | $16 rb | -$211 rb | -$26 rb | |
| Perubahan neto kas | $18,3 jt | $140 jt | -$152 jt | $6,43 jt | -$23,7 jt | $11,3 jt | -$4,06 jt | $66,5 jt | $65,4 jt | -$47,7 jt | $7,63 jt | $552 jt | |
| Arus kas bebas (OCF - capex) | -$17,6 jt | -$6,13 jt | -$28,5 jt | -$22 jt | -$31,2 jt | -$52,3 jt | -$47,1 jt | -$94 jt | -$85,3 jt | -$114 jt | -$125 jt | -$138 jt | |
| Arus kas | Tren | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operasional | |||||||||||
| Laba bersih | -$14,7 jt | -$20,6 jt | -$22,1 jt | -$25,8 jt | -$39,5 jt | -$55 jt | -$68,9 jt | -$85,9 jt | -$110 jt | -$360 jt | |
| Depresiasi & amortisasi | $1,93 jt | $19,1 jt | $26,2 jt | $260 rb | $277 rb | $296 rb | $291 rb | $292 rb | $346 rb | $431 rb | |
| Kompensasi berbasis saham | $1,79 jt | $1,45 jt | $2,61 jt | $3,74 jt | $5,82 jt | $6,1 jt | $8,67 jt | $16,8 jt | $29,7 jt | $40,8 jt | |
| Pajak penghasilan tangguhan | -$1,79 jt | -$1,28 jt | -$392 rb | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Perubahan modal kerja | $850 rb | $1,77 jt | $823 rb | -$3,78 jt | $7,72 jt | -$2,93 jt | $10,2 jt | $3,55 jt | $9,36 jt | $49 jt | |
| Pos non-kas lainnya | $878 rb | -$15,2 jt | -$25,9 jt | $807 rb | $3,91 jt | $3,94 jt | $1,32 jt | -$8,07 jt | -$17,2 jt | -$9,27 jt | |
| Arus kas operasional | -$11,1 jt | -$14,8 jt | -$18,8 jt | -$24,8 jt | -$21,8 jt | -$47,6 jt | -$48,4 jt | -$73,4 jt | -$87,8 jt | -$279 jt | |
| Investasi | |||||||||||
| Pembelian investasi | -$16,9 jt | -$22,5 jt | -$348 jt | -$362 jt | -$281 jt | -$168 jt | -$121 jt | -$478 jt | -$1,11 M | -$418 jt | |
| Penjualan / jatuh tempo investasi | $20 jt | $20,8 jt | $82,5 jt | $370 jt | $322 jt | $206 jt | $176 jt | $299 jt | $560 jt | $759 jt | |
| Aktivitas investasi lainnya | $3,03 rb | -$1,73 rb | -$266 rb | $0 | $0 | $0 | $54,8 rb | $0 | $0 | $0 | |
| Arus kas investasi | $3,03 jt | -$1,73 jt | -$266 jt | $7,46 jt | $41,6 jt | $38 jt | $54,8 jt | -$179 jt | -$553 jt | $341 jt | |
| Pendanaan | |||||||||||
| Utang neto diterbitkan / dilunasi | -$94,9 rb | -$77 rb | -$3,83 jt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Pembelian kembali saham | -$229 | $0 | $0 | $0 | $0 | $0 | -$6,8 jt | $0 | $0 | $0 | |
| Pendanaan lainnya (termasuk pajak atas saham yang vested) | -$1,1 jt | $125 rb | $7,5 jt | -$151 rb | -$296 rb | -$707 rb | $12,5 jt | $1,62 jt | $15,4 jt | $73,9 jt | |
| Arus kas pendanaan | $10,3 jt | $22,4 jt | $300 jt | $887 rb | $950 rb | $6,88 jt | $4,16 jt | $271 jt | $612 jt | $76,4 jt | |
| Ringkasan | |||||||||||
| Efek kurs terhadap kas | $0 | $0 | $0 | $0 | $0 | $0 | -$258 rb | -$30 rb | -$148 rb | -$8 rb | |
| Perubahan neto kas | $2,31 jt | $5,91 jt | $15,8 jt | -$16,4 jt | $20,7 jt | -$2,75 jt | $10,3 jt | $18,9 jt | -$28,8 jt | $139 jt | |
| Arus kas bebas (OCF - capex) | -$11,1 jt | -$14,8 jt | -$18,8 jt | -$24,8 jt | -$21,8 jt | -$47,6 jt | -$48,4 jt | -$73,4 jt | -$87,8 jt | -$279 jt | |
Distandardisasi dari laporan perusahaan; arus keluar dan biaya mempertahankan tanda yang dilaporkan penyedia. Arahkan kursor ke periode untuk melihat tanggal berakhirnya. Jumlah dalam USD.
Arus kas operasional, capex, arus kas bebas
kuartalanPenggunaan kas vs arus kas operasional
tahun fiskalJumlah saham dan EPS
kuartalan, dilusianLaporan lainnya
Sumber
Laporan keuangan, pendapatan segmen, metrik, dan estimasi distandardisasi dari laporan perusahaan. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data per 2026-11-02